Is the prognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients? A comparative analysis of clinical characteristics, prognostic features, and survival outcome

Journal of Gastroenterology

Volumn 43, Issue 11, 2008, Pages 881-888

  Chang, Pik Eu ^a   Ong, Wai Choung ^a   Lui, Hock Foong ^a   Tan, Chee Kiat ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Hepatocellular carcinoma; Old; Prognosis; Survival; Young

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN;

ADULT; ADVANCED CANCER; AGE; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILD PUGH SCORE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PORTAL VEIN; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SCORING SYSTEM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOGRAPHY; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SINGAPORE; SURVIVAL RATE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 56649107784     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-008-2238-x     Document Type: Article

References (36)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001;2:533-543.
2. Seow A, Koh WP, Chia KS, Shi LM, Lee HP, Shanmugaratnam K. Trends in cancer incidence in Singapore 1968-2002, Singapore Cancer Registry Report No. 6.
3. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999;19:271-285.
4. Kew MC, Rossouw E, Hodkinson J, Paterson A, Dusheiko GM, Whitcutt JM. Hepatitis B virus status of South African blacks with hepatocellular carcinoma: Comparison between rural and urban patients. Hepatology 1983;3:65-68.
5. Namieno T, Kawata A, Sato N, Kondo Y, Uchino J. Age-related, different clinicopathologic features of hepatocellular carcinoma patients. Ann Surg 1995;221:308-314.
6. Falkson G, Cnaan A, Schutt AJ, Ryan LM, Falkson HC. Prognostic factors for survival in hepatocellular carcinoma. Cancer Res 1998;48:7314-7318.
7. Ni YH, Chang MH, Hsu HY, Hsu HC, Chen CC, Chen WJ, et al. Hepatocellular carcinoma in childhood. Clinical manifestations and prognosis. Cancer 1991;68:1737-1741.
8. Cho SJ, Yoon JH, Hwang SS, Lee HS. Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients? J Gastroenterol Hepatol 2007;22:1226-1231.
9. Chen CH, Chang TT, Cheng KS, Su WW, Yang SS, Lin HH, et al. Do young hepatocellular carcinoma patients have a worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients. Liver Int 2006;26:766-773.
10. Ng IO, Ng MM, Lai EC, Fan ST. Pathologic features and patient survival in hepatocellular carcinoma in relation to age. J Surg Oncol 1996;61:134-137.
11. Lam CM, Chan AO, Ho P, Ng IO, Lo CM, Liu CL, et al. Different presentation of hepatitis B-related hepatocellular carcinoma in a cohort of 1863 young and old patients - implications for screening. Aliment Pharmacol Ther 2004;19:771-777.
12. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 1981;2:1129-1133.
13. Oka H, Kurioka N, Kim K, Kanno T, Kuroki T, Mizoguchi Y, et al. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990;12:680-687.
14. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial for screening of hepatocellular carcinoma. J Cancer Res Clin Oncol 2004;130:417-422.
15. Wong LL, Limm WM, Severino R, Wong LM. Improved survival with screening for hepatocellular carcinoma. Liver Transpl 2000;6:320-325.
16. Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988;61:1942-1956.
17. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Christensen E, et al. Clinical management of hepatocellular carcinoma: Conclusions of the Barcelona-2000 EASL conference. J Hepatol 2001;35:421-430.
18. Bruix J, Sherman M. AASLD Practice guideline: Management of hepatocellular carcinoma. Hepatology 2005;42:1208-1236.
19. Aramaki M, Kawano K, Sasaki A, Ohno T, Tahara K, Kai S, et al. Hepatocellular carcinoma in young adults. Hepatogastroenterology 2005;52:1795-1797.
20. Klein WM, Molmenti EP, Colombani PM. Primary liver carcinoma arising in people younger than 30 years. Am J Clin Pathol 2005;124:512-518.
21. Hernandez-Castillo E, Mondragon-Sanchez R, Garduno-Lopez AL, Gomez-Gomez E, Ruiz-Molina JM, Onate-Ocana LF, et al. Hepatocellular carcinoma in the youth. A comparative analysis with hepatocellular carcinoma in adulthood. Hepatogastroenterology 2005;52:903-907.
22. Sezaki H, Kobayashi M, Hosaka T, Someya T, Akuta N, Suzuki F, et al. Hepatocellular carcinoma in noncirrhotic young adult patients with chronic hepatitis B viral infection. J Gastroenterol 2004;39:550-556.
23. Yamazaki Y, Kakizaki S, Sohara N, Sato K, Takagi H, Arai H, et al. Hepatocellular carcinoma in young adults: The clinical characteristics, prognosis and findings of a patient survival analysis. Dig Dis Sci 2007;52:1103-1107.
24. Kim JH, Choi MS, Lee H, Kim DY, Lee JH, Koh KC, et al. Clinical features and prognosis of hepatocellular carcinoma in young patients from a hepatitis B-endemic area. J Gastroenterol Hepatol 2006;21:588-594.
25. Wan J, Grossman HB. Bladder carcinoma in patients age 40 years or younger. Cancer 1989;64:178-181.
26. Shaha AR, Shah JP, Loree TR. Risk group stratification and prognostic factors in papillary carcinoma of thyroid. Ann Surg Oncol 1996;3:534-538.
27. Leff DR, Chen A, Roberts D, Grant K, Western C, Windsor AC, et al. Colorectal cancer in the young patient. Am Surg 2007;73:42-47.
28. Adami HO, Malker B, Holmberg L, Persson I, Stone B. The relation between survival and age at diagnosis in breast cancer. N Engl J Med 1986;315:559-563.
29. Katai H, Sasako M, Sano T, Maruyama K. Gastric carcinoma in young adults. Jpn J Clin Oncol 1996;26:139-143.
30. Lai IR, Lee WJ, Chen CN, Lee PH, Chang KJ, Chang-Yu S, et al. Gastric cancer in the young. Hepatogastroenterology 1997;44:1641-1645.
31. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: Worldwide incidence and trends. Gastroenterology 2004;127:S5-S16.
32. Feitelson MA, Duan LX. Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Am J Pathol 1997;150:1141-1157.
33. Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Eng J Med 2002;347:168-174.
34. Evans AA, Chen G, Ross EA, Shen FM, Lin WY, London WT. Eight year follow-up of the 90,000 person Haimen City cohort: Hepatocellular carcinoma mortality, risk factors and gender differences. Cancer Epidemiol Biomarkers Prev 2002;11:369-376.
35. Huo TI, Wu JC, Lee PC, Chau GY, Lui WY, Tsay SH, et al. Seroclearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology 1998;28:231-236.
36. Yuen MF, Wong DK, Sablon E, Tse E, Ng IO, Yuan HJ, et al. HBsAg seroclearance in chronic hepatitis B in the Chinese: Virological, histological and clinical aspects. Hepatology 2004;39:1694-1701.